89 related articles for article (PubMed ID: 7909855)
1. [Gene diagnosis of uterine cervical cancer].
Nagai N
Rinsho Byori; 1994 Apr; 42(4):372-9. PubMed ID: 7909855
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
Milde-Langosch K; Wilckens C; Brack T; Löning T
Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
[TBL] [Abstract][Full Text] [Related]
4. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
5. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas.
Iwasaka T; Yokoyama M; Oh-uchida M; Matsuo N; Hara K; Fukuyama K; Hachisuga T; Fukuda K; Sugimori H
Gynecol Oncol; 1992 Sep; 46(3):298-303. PubMed ID: 1326470
[TBL] [Abstract][Full Text] [Related]
6. [The possibility of viral etiology in cervical carcinogenesis].
Iwasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
8. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
Ocádiz R; Sauceda R; Salcedo M; Ortega V; Rodríguez H; Gordillo C; Chávez P; Gariglio P
Arch Invest Med (Mex); 1989; 20(4):355-62. PubMed ID: 2562235
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
11. The c-myc activation in cervical carcinomas and HPV 16 infections.
Abba MC; Laguens RM; Dulout FN; Golijow CD
Mutat Res; 2004 Feb; 557(2):151-8. PubMed ID: 14729369
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus, human cytomegalovirus and oncogene C-myc in cervical carcinoma and cervicitis.
Huang SL; Liu ZQ; Zhang XN; Li MJ
Chin Med J (Engl); 1993 Mar; 106(3):208-10. PubMed ID: 8391967
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of prognostic factors in gynecological cancer examined by molecular biological study].
Nagai N
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1004-9. PubMed ID: 8687214
[TBL] [Abstract][Full Text] [Related]
14. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
Huang G; Xiao X; Huang Y; Huang R
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.
Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL
Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
18. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
19. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract][Full Text] [Related]
20. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
